does the energy expenditure claim show up as anything you can feel
#retatrutide 2025-02-07
Friday38 messages9 participantstimes are UTC
Highlights from this day
anyone tracking blood pressure alongside the heart rate
held mine ages
reconstituted the 30 vial to 10mg/ml specifically so i could take 2 without measuring crumbs
quick one stopped for 6 months and restarted at half my old dose, the ramp was easier second time
unrelated but triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history
energy expenditure isnt something i could feel, though my sleep tracker disagreed with me
low and slow here means smaller steps than i ever used on tirzepatide, thats the received wisdom
anyone reconstituting 10 vials to 5 so the steps come out smaller
triple agonist yeah
the honest position is this has less human evidence behind it than anything else discussed here
glucagon is the new bit
mine went up too
whats the half life like, is it weekly the same way
watching my heart rate
medutest-report-a-2601.pdf
3 pages · 285 KB · not retained in the public archive
follow up no idea whether the heart rate settles for everyone, mine did and one log isnt data
👀15⚠️10
TRIUMPH is the phase 3 programme, thats the name to search rather than the molecule
Digest for the week of 2024-07-19 has been published.
🤝6💀12
quick one my resting heart rate is up about 7 bpm, did that settle for anyone
follow up how do people square the research use only framing with logging their own use
baseline 58
wk 2 61
wk 4 64
wk 6 67
wk 8 66
wk 10 65 (held dose from wk 7)settled by month three
how long before people saw the first change at 0.25
smaller steps here
research use only is on every vial and i treat it as exactly that, nobody here is prescribing
no long term data
research use only
TRIUMPH is phase 3
i went up too fast, got a fortnight of nothing but nausea, and dropped back two steps
🧪5⚠️3✅12
the heart rate thing is real enough that i mention it whenever someone asks about starting
phase 2 only
📈6📉15🧪1
did the phase 2 result actually come in higher than the tirzepatide numbers
coa-a-2418.pdf
1 page · 230 KB · not retained in the public archive
genuine question the half life supports weekly dosing and thats what ive done from the start, take that with a pinch of salt
there is no long term safety data, phase 2 and an ongoing phase 3 programme is what exists
buying this is a completely different risk conversation from the licensed compounds and that gets said too rarely
genuine question anyone compared their Medutest purity across two different QYB lots
back after 24 months, has anything actually been published since
is the GI worse than tirzepatide or about the same
anyone stayed at 0.25 for months rather than climbing
[edited]did the phase 2 plateau or was it still moving at the end